Equities

Pure Biologics SA

Pure Biologics SA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (PLN)22.00
  • Today's Change1.10 / 5.26%
  • Shares traded131.90k
  • 1 Year change+64.18%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Pure Biologics SA is a manufacturer of biological products. The Company was founded in August 2010 and is located in Wroclaw, Poland.

  • Revenue in PLN (TTM)69.00k
  • Net income in PLN-33.63m
  • Incorporated2018
  • Employees29.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Inno-Gene SA462.00k-6.12m16.74m27.00--5.95--36.24-1.06-1.060.07760.45350.06250.97371.39---82.831.90-115.272.58-44.1676.43-1,325.332.661.20-1.000.0106---93.14-16.73-2,069.21------
Braster SA284.00k-4.30m16.86m10.00------59.38-0.1494-0.14940.0098-0.17170.01350.00382.7028,400.00-20.43-29.93-147.09-72.5493.6679.59-1,513.38-1,124.890.2905-2.661.77---88.96-18.1128.68------
Sygnis SA12.42m-5.52m17.57m34.00--0.4881--1.41-0.2396-0.23960.53141.430.17520.619415.06326,799.50-7.89-5.73-14.77-8.3160.8256.42-45.06-21.110.4425-0.74120.1151---33.3844.26-241.23--39.45--
Milestone Medical Inc28.28k-13.47m34.76m4.00------1,228.98-0.6122-0.61220.0013-4.920.01090.59180.1213---517.54-340.87-----3,337.03-166.46-47,612.84-5,029.090.0067-34.89-----65.3492.41-16.23------
GENOMED SA22.14m588.66k37.00m44.0062.853.9930.981.670.44550.445516.757.022.175.8514.12503,111.405.777.776.399.1944.0038.532.663.874.6430,446.000.00--9.883.88174.07-8.94-32.19--
Medicofarma Biotech SA1.37m-2.73m37.93m----4.36--27.71-0.0402-0.04020.02010.1280.08954.574.74---17.87-15.05-23.82-18.1781.9229.92-199.65-42.860.8394-18.900.00---82.34-31.48-116.39------
Read Gene SA11.63m-1.00m69.09m11.00--37.03--5.94-0.1084-0.10841.160.15830.973151.3218.69---8.40-1.06-8.56-1.3192.6788.41-8.63-2.4223.52-2.460.00--40.1416.00-731.53------
Pure Biologics SA69.00k-33.63m81.24m29.00------1,177.38-10.40-10.400.0213-0.92460.0015--0.20751,352.94-72.94-65.91-99.86-109.50-2,439.136.97-48,734.78-487.38---8.411.30---85.65-60.22-39.41--1.65--
Sds Optic SA370.00-8.98m82.87m--------223,982.30-1.52-1.520.00006-0.05450.0000365.750.0006---74.69---86.32---371,002.80---2,452,795.00--9.61-47.49-----99.61---85.09------
Genomtec SA-89.00k-9.59m98.06m----17.37-----0.8159-0.8159-0.00760.4604-0.006427.93-----68.62---107.95----------1.12-58.910.2064---97.50--24.44------
Nanogroup SA-24.98k-7.35m100.73m----25.65-----0.3477-0.3477-0.00120.1587-0.00167.38-----47.32-23.18-59.79-26.06---278.03---1,567.570.4541-2,241.440.00---98.55-55.07-840.84---8.99--
Urteste SA0.00-5.49m134.20m----5.08-----4.21-4.210.0018.74------------------------16.97--0.0263---100.00---37.59------
Molecure SA360.18k-21.91m235.37m112.00--2.50--653.47-1.35-1.350.02235.590.003--0.07413,244.87-18.172.64-19.292.76-444.0197.54-6,082.4012.84----0.0657---18.85237.24-19.67---24.82--
Data as of Sep 20 2024. Currency figures normalised to Pure Biologics SA's reporting currency: Polish New Zloty PLN

Institutional shareholders

3.44%Per cent of shares held by top holders
HolderShares% Held
Allianz Polska TFI SAas of 31 Dec 202366.15k1.79%
Norges Bank Investment Managementas of 31 Dec 202361.00k1.65%
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.